SCHEMBL1935112

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL185440	0.79	CHEK1 (0.51)	—
	SCHEMBL16481026	0.75	ACP1 (0.61)	ALDH1A1TAS2R14MAPTMAPK1CACNA1B
	SCHEMBL22563041	0.73	TAS2R14 (0.56)	ALDH1A1TDP1TAS2R14MAPTMAPK1
	SCHEMBL16481443	0.73	SLC22A12 (0.55)	AURKAALDH1A1TDP1TAS2R14MAPT
	SCHEMBL27962647	0.72	ALDH1A1 (0.49)	AURKAALDH1A1TDP1MAPTMAPK1
	SCHEMBL1935087	0.72	AR (0.57)	ALDH1A1TGFBR1MAPK1
	SCHEMBL1921413	0.71	ALDH1A1 (0.57)	AURKAALDH1A1TDP1TAS2R14MAPT
	SCHEMBL1935748	0.70	MAOB (0.51)	KDR
	SCHEMBL2592058	0.69	AURKA (0.59)	AURKAALDH1A1TDP1MAPTMAPK1
	SCHEMBL1933633	0.69	AR (0.50)	KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.